# US 2018/0105821 A1 · TaBV TRANSCRIPTIONAL CONTROL ELEMENTS, CHIMERIC CONSTRUCTS AND USES THEREFOR

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0105821 A1
- Document ID: US20180105821A1
- Status: Published application
- Kind: A1
- Application number: 15/194,766
- Filed: 2016-06-28
- Published: 2018-04-19
- Earliest claimed: 2002-07-17
- Assignees: Farmacule Bioindustries Pty Ltd
- Inventors: James Langham DALE; Robert Maxwell Harding; Douglas Kenneth Becker; Gregory John Hafner; llin Yang
- Web page: https://patentgrep.com/patent/US20180105821A1

## CPC

- C12N 15/8216: {Methods for controlling, regulating or enhancing expression of transgenes in plant cells}
- A61P 31/12: Antivirals
- C07K 14/005: from viruses
- C12N 15/8222: {Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation}
- C12N 15/8223: {Vegetative tissue-specific promoters}
- C12N 2730/00022: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

This invention discloses a constitutive promoter from the Taro bacilliform virus (TaBV) for expression of foreign or endogenous coding sequences in plants, including dicotyledonous and monocotyledonous plants. The invention also discloses a chimeric nucleic acid construct comprising the promoter of the invention operably linked to a foreign or endogenous polynucleotide that codes for a protein of interest or a transcript capable of modulating expression of a target gene. The invention further discloses transformed plant cells, as well as differentiated plants and plant parts, containing the construct. Methods for diagnosis and treatment of viral infections, especially badnaviral infections, are also disclosed.

## Claims

### Claim at position 1

1-69. (canceled)

### Claim 70

A chimeric DNA construct comprising a DNA molecule operably linked to a foreign or endogenous DNA sequence to be transcribed, wherein the DNA molecule has at least 95% sequence identity, or hybridizes under high stringency conditions, to a biologically active fragment of the sequence set forth in SEQ ID NO:6, wherein the biologically active fragment comprises nucleotides 527 to 970 of SEQ ID NO:6, wherein the high stringency conditions comprise 1% BSA, 1 mM EDTA, 0.5 M NaHPO4 (pH 7.2), and 7% SDS for hybridization at 65° C. and washing at 68° C. in 0.2×SSC, 0.1% SDS.

### Claim 71 (depends on 70)

The construct of claim 70, further comprising a 3′ non-translated sequence that is operably linked to the foreign or endogenous DNA sequence and that functions in plant cells to terminate transcription and/or to cause addition of a polyadenylated nucleotide sequence to the 3′ end of a transcribed RNA sequence.

### Claim 72 (depends on 70)

The construct of claim 70, wherein the foreign or endogenous DNA sequence encodes a structural or regulatory protein.

### Claim 73 (depends on 70)

The construct of claim 70, wherein the foreign or endogenous DNA sequence encodes a transcript capable of modulating expression of a corresponding target gene.

### Claim 74 (depends on 73)

The construct of claim 73, wherein the transcript comprises a transcribed region aimed at downregulating the expression of the corresponding target gene.

### Claim 75 (depends on 73)

The construct of claim 73, wherein the transcript comprises a transcribed region that represents a molecule selected from the group consisting of a sense suppression molecule, an antisense RNA, a ribozyme and an RNAi molecule.

### Claim 76 (depends on 70)

The construct of claim 70, further comprising a leader sequence which modulates mRNA stability.

### Claim 77 (depends on 70)

The construct of claim 70, further comprising a targeting sequence for targeting a protein product of the foreign or endogenous DNA sequence to an intracellular compartment within plant cells or to an extracellular environment.

### Claim 78 (depends on 70)

The construct of claim 70, further comprising a selectable marker gene.

### Claim 79 (depends on 70)

The construct of claim 70, further comprising a screenable marker gene.

### Claim 80 (depends on 70)

The construct of claim 70, wherein the nucleotide sequence is constitutively expressed in a host cell.

### Claim 81 (depends on 80)

The construct of claim 80, wherein the host cell is a plant cell.

### Claim 82 (depends on 80)

The construct of claim 80, wherein the host cell is a monocotyledonous plant cell.

### Claim 83 (depends on 80)

The construct of claim 80, wherein the host cell is a non-graminaceous monocotyledonous plant cell.

### Claim 84 (depends on 80)

The construct of claim 80, wherein the host cell is a non-graminaceous monocotyledonous plant cell selected from the group consisting of Musaceae, taro, ginger, onions, garlic, pineapple, bromeliads, palms, orchids, lilies and irises.

### Claim 85 (depends on 80)

The construct of claim 80, wherein the host cell is a graminaceous monocotyledonous plant cell.

### Claim 86 (depends on 80)

The construct of claim 80, wherein the host cell is a dicotyledonous plant cell.

### Claim 87

A progeny obtained from a differentiated transgenic plant comprising a chimeric construct, wherein the differentiated plant is produced by a method comprising:
(a) introducing into regenerable plant cells a chimeric DNA construct comprising a DNA molecule operably linked to a foreign or endogenous DNA sequence to be transcribed, wherein the DNA molecule has at least 95% sequence identity, or hybridizes under high stringency conditions, to a biologically active fragment of the sequence set forth in SEQ ID NO:6, wherein the biologically active fragment comprises nucleotides 527 to 970 of SEQ ID NO:6, wherein the high stringency conditions comprise 1% BSA, 1 mM EDTA, 0.5 M NaHPO4 (pH 7.2), and 7% SDS for hybridization at 65° C. and washing at 68° C. in 0.2×SSC, 0.1% SDS;
(b) identifying or selecting a population of transformed plant cells; and
(c) regenerating a differentiated transgenic plant from the population.

### Claim 88

A plant part obtained from a differentiated transgenic plant produced by a method comprising the steps of:
(a) introducing into regenerable plant cells a chimeric DNA construct comprising a DNA molecule operably linked to a foreign or endogenous DNA sequence to be transcribed, wherein the DNA molecule has at least 95% sequence identity, or hybridizes under high stringency conditions, to a biologically active fragment of the sequence set forth in SEQ ID NO:6, wherein the biologically active fragment comprises nucleotides 527 to 970 of SEQ ID NO:6, wherein the high stringency conditions comprise 1% BSA, 1 mM EDTA., 0.5 M NaHPO4 (pH 7.2), and 7% SDS for hybridization at 65° C. and washing at 68° C. in 0.2×SSC, 0.1% SDS;
(b) identifying or selecting a population of transformed plant cells; and
(c) regenerating a differentiated transgenic plant from the population;
wherein the plant part contains the chimeric construct.

### Claim 89

A differentiated transgenic plant regenerated from transformed plant cells obtained by a method comprising the steps of:
(a) introducing into regenerable plant cells a chimeric DNA construct comprising a DNA molecule operably linked to a foreign or endogenous DNA sequence to be transcribed, wherein the DNA molecule has at least 95% sequence identity, or hybridizes under high stringency conditions, to a biologically active fragment of the sequence set 1.5 forth in SEQ ID NO:6, wherein the biologically active fragment comprises nucleotides 527 to 970 of SEQ ID NO:6, wherein the high stringency conditions comprise 1% BSA, 1 mM EDTA, 0.5 M NaHPO4 (pH 7.2), and 7% SDS for hybridization at 65° C. and washing at 68° C. in 0.2×SSC, 0.1% SDS;
(b) identifying or selecting a population of transformed plant cells; and
(c) regenerating a differentiated transgenic plant from the population.

### Claim 90

A transformed plant cell containing a chimeric DNA construct comprising a DNA molecule operably linked to a foreign or endogenous DNA sequence to be transcribed, wherein the DNA molecule has at least 95% sequence identity, or hybridizes under high stringency conditions, to a biologically active fragment of the sequence set forth in SEQ ID NO:6, wherein the biologically active fragment comprises nucleotides 527 to 970 of SEQ ID NO:6, wherein the high stringency conditions comprise 1% BSA, 1 mM EDTA, 0.5 M NaHPO4 (p1-1 7.2), and 7% SDS for hybridization at 65° C. and washing at 68° C. in 0.2×SSC, 0.1% SDS.

### Claim 91

A differentiated transgenic plant comprising plant cells containing a chimeric DNA construct comprising a DNA molecule operably linked to a foreign or endogenous DNA sequence to be transcribed, wherein the DNA molecule has at least 95% sequence identity, or hybridizes under high stringency conditions, to a biologically active fragment of the sequence set forth in SEQ ID NO:6, wherein the biologically active fragment comprises nucleotides 527 to 970 of SEQ ID NO:6, wherein the high stringency conditions comprise 1% BSA, 1 mM EDTA, 0.5 M NaHPO4 (pH 7.2), and 7% SDS for hybridization at 65° C. and washing at 68° C. in 0.2×SSC, 0.1% SDS.

### Claim 92 (depends on 91)

The transgenic plant of claim 91, wherein the plant is a dicotyledonous plant.

### Claim 93 (depends on 91)

The transgenic plant of claim 91, wherein the plant is a monocotyledonous plant.

### Claim 94 (depends on 91)

The transgenic plant of claim 91, wherein the plant is a graminaceous monocotyledonous plant.

### Claim 95 (depends on 91)

The transgenic plant of claim 91, wherein the plant is a non-graminaceous monocotyledonous plant.

### Claim 96 (depends on 91)

The transgenic plant of claim 91, wherein the construct comprises a selectable marker gene.

### Claim 97 (depends on 91)

The transgenic plant of claim 91, wherein the construct comprises a screenable marker gene.

### Claim 98 (depends on 91)

The transgenic plant of claim 91, wherein the expression of the chimeric DNA construct renders the differentiated transgenic plant identifiable over the corresponding non-transgenic plant.
